Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,205 public trials 1,002 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

NCT03944772

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
  • Research Site Santa Monica, California, United States
View all 47 locations
View Trial Details
Active, Not Recruiting

Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)

NCT04597671

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • ZGT Almelo, Netherlands
  • AmsterdamUMC - location VUmc Amsterdam, Netherlands
  • Radiotherapie Groep Arnhem, Netherlands
  • Rijnstate Arnhem, Netherlands
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study of AL8326 in Non-Small Cell Lung Cancer

NCT06794957

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The First Affiliated Hospital of Bengbu Medicaal University Bengbu, Anhui, China
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • Xuancheng People´s Hospital Xuancheng, Anhui, China
  • Anyang Cancer Hospital Anyang, Henan, China
View Trial Details
Active, Not Recruiting

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

NCT04685135

Conditions
Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • Local Institution - 012-898 Cerritos, California, United States
  • City of Hope - Duarte (Main Campus) Duarte, California, United States
  • Local Institution - 012-898 D Glendale, California, United States
  • Local Institution - 012-910-A Huntington Beach, California, United States
View all 343 locations
View Trial Details
Active, Not Recruiting

A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors

NCT04440735

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations
  • Moores Cancer Center, UCSD La Jolla, California, United States
  • University of Colorado Hospital, Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
View Trial Details
Active, Not Recruiting

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS

NCT05688280

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +36 more
Locations
  • Miami Cardiac & Vascular Institute Coral Gables, Florida, United States
  • University of Louisville Physicians, PSC Louisville, Kentucky, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Institut Bergonie Bordeaux, France
View all 16 locations
View Trial Details
Active, Not Recruiting

Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)

NCT05712902

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital，Capital Medical University Beijing, China
  • Peking Union Medical College Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
View all 33 locations
View Trial Details
Active, Not Recruiting

A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil

NCT06008353

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • ÉTICA Clínica AMO - Assistência Multidisciplinar em Oncologia Salvador, Estado de Bahia, Brazil
  • Oncologia D'Or Unidade Esperança Pernambuco Recife, Pernambuco, Brazil
  • Instituto D'Or de Pesquisa e Ensino RJ Rio de Janeiro, Brazil
  • BP - A Beneficência Portuguesa de São Paulo São Paulo, Brazil
View Trial Details

Related conditions